New‐Onset Headache After <scp>SARS</scp> ‐ <scp>CoV</scp> ‐2 Infection and Vaccination: Results From Three Population‐Based Cohorts in Norway
SARS-CoV-2 infection was strongly associated with new-onset headache. Primary vaccination was associated with a small increased risk of headache during a low-transmission period, whereas booster vaccination offered protection during high-transmission.
Authors
- Anna Hayman Robertson (ORCID: https://orcid.org/0000-0001-6295-0528)
- Lill Trogstad (ORCID: https://orcid.org/0000-0002-9557-5725)
- Per Magnus (ORCID: https://orcid.org/0000-0002-6427-4735)
- Ida Henriette Caspersen (ORCID: https://orcid.org/0000-0003-2591-8435)
- Siri N. Skodvin (ORCID: https://orcid.org/0000-0003-4545-2513)
- Berit Feiring (ORCID: https://orcid.org/0000-0003-1505-1671)
- Kristine Blix (ORCID: https://orcid.org/0009-0007-7838-0161)
- Anker Stubberud (ORCID: https://orcid.org/0000-0003-0934-9914)
- Marte‐Helene Bjørk (ORCID: https://orcid.org/0000-0002-5745-1094)
- Siri Mjaaland (ORCID: https://orcid.org/0000-0002-3870-5861)
- Ida Laake (ORCID: https://orcid.org/0000-0002-0546-896X)
Institutions
- Norwegian Institute of Public Health (NO)
- Norwegian University of Science and Technology (NO)
- NORCE Research AS (NO)
Publication Details
- Journal
- European Journal of Neurology
- Published
- 2025-12-01
- DOI
- https://doi.org/10.1111/ene.70437
- Primary Topic
- Long-Term Effects of COVID-19
- Type
- article
- Field-Weighted Citation Impact
- 0.00